Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
104.00    -7.00 (-6.31%)
Bid:
103.00
Ask:
105.00
Spread: 2.00 (1.942%)
Market Cap: £62.57m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Appointment of Adviser

9 Mar 2017 07:00

RNS Number : 9216Y
Intercede Group PLC
09 March 2017
 

 

 

9 March 2017

INTERCEDE GROUP plc

("Intercede" or "the Company")

Appointment of Adviser

 

Intercede today announces that it has appointed Capital Access Group ("CAG") as its investor relations adviser. CAG will support the Company in the development of its equity capital market communications with a specific focus on shareholder engagement and new investor targeting.

The Company has recently published a trading update (3 March 2017) which highlighted the considerable revenue opportunities facing Intercede in the medium term. This is a function of the likely positive impact of, amongst other factors, the US Government's cybersecurity initiative and the forthcoming EU directive on payment services, both of which are expected to expand Intercede's addressable markets considerably.

CAG will support the company in communicating this potential to shareholders and new investors alike.

Commenting on the appointment, Richard Parris, Chairman and CEO of Intercede, said;

"Intercede is facing a significant step change in its prospects. We have developed our market leading intellectual property to build on the success of MyID with the launch of RapID for transactions on mobile devices and the roll out of MyTAM for applications in the IoT. These initiatives are designed to address the potential offered by the structural trend towards multi-factor authentication and away from traditional password security. It is important that the Company is able to articulate clearly the significant potential this holds for our business and the markets which it addresses."

 

ENQUIRIES

 

Intercede Group plc Tel. +44 (0)1455 558 111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

 

finnCap Tel. +44 (0)20 7220 0500

Stuart Andrews, Corporate Finance

Simon Hicks, Corporate Finance

 

Capital Access Group Tel. +44 (0)203 763 3400

Scott Fulton

Ed Welsby

 

 

About Intercede

Intercede is a software and service company specializing in identity, credential management and secure mobility. Its solutions create a foundation of trust between connected people, devices and apps and combine expertise with innovation to provide world-class cybersecurity. Intercede has been delivering solutions to high profile customers, from the US and UK governments to some of the world's largest corporations, telecommunications providers and information technology firms, for over 20 years. Intercede's product portfolio includes MyID, an identity and credential management system that assigns trusted digital identities to employees citizens and machines. In 2015, Intercede launched MyTAM, enabling trusted applications to be loaded into a mobile device's Trusted Execution Environment (TEE), providing hardware-level security for Android apps. In 2016, Intercede launched RapID, a secure, easy to implement authentication service for mobile apps and cloud services to completely eliminate the need for passwords.

 

For more information visit: www.intercede.com

 

About Capital Access Group (CAG)

Capital Access Group advises companies on effective engagement with investors. Its services range from corporate access, investment research, investor targeting, data analytics and perception studies. CAG focuses on relationships with Private Client Fund Managers (PCFMs), regional pension funds and wealth managers. Currently, it acts for over 60 UK companies from FTSE 100 constituents to AIM listed entities. Its investment audience consists of over 500 individual firms and over 4,500 fund managers with combined Assets under Management (AuM) of over £650bn.

For more information visit: www.capitalaccessgroup.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUWABRBWAORAR
Date   Source Headline
23rd Jun 20267:00 amRNSFinal Results
15th Jun 20267:00 amRNS-RExtension of Partnership with Swissbit
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.